Clinical Trials Logo
  1. Home
  2. Schizophrenia
  3. NCT00153959
  4. Details
NCT00153959 Clinical Trial

Psychiatric Day Hospital Treatment

Schizophrenia Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00153959
Other study ID # QLG4-CT-2000-01700
Secondary ID
Status Completed
Phase N/A
First received September 7, 2005
Last updated September 7, 2005

Study information
Verified date September 2005
Source Technische Universität Dresden
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

The aim of the study was to compare the effectiveness of acute psychiatric day care to conventional inpatient care within a cross-national multi-site randomised controlled trial.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients must have presented with a mental disorder with current symptoms that had either led to at least a moderate disturbance in performance in more than one area of daily living or had jeopardized the residential, financial or occupational status of the patient or his family

- Treatments other than inpatient or day hospital care must have been inadequate or not sufficiently effective for the patient’s current mental state

Exclusion Criteria:

- Temporary admission for diagnostic purposes or for other reasons

- Under 18 or over 65 years

- Admission without consent of the patient (according to country-specific legal regulations)

- One-way journey to hospital longer than 60 minutes

- Suicidal risk

- Risk to others

- Degree of severity of the disorder requires measures restrictive of the patient's freedom on the day of admission, or a 1:1 supervision, or deems such probable

- Acute intoxication

- Main clinical diagnosis: addictive disorder

- Presence of a somatic disorder requiring inpatient care

- Direct transfer from a different hospital

- Homelessness

- Need for constant pick-up and delivery service

- Inability to give informed consent with respect to participating in the study

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label

Related Conditions & MeSH terms

Intervention

Behavioral:
• acute psychiatric day care

Locations
Country Name City State
Czech Republic Department of Psychiatry, First Medical Faculty, Charles University of Prague Prague 2
Germany Department of Psychiatry at Dresden University of Technology Dresden Saxony
Poland Department of Psychiatry, Wroclaw University of Medicine Wroclaw
Slovakia Michalovce Psychiatric Hospital Michalovce
United Kingdom Unit for Social and Community Psychiatry, Barts’ and The London School of Medicine London

Sponsors (1)
Lead Sponsor Collaborator
Technische Universität Dresden

Countries where clinical trial is conducted

Czech Republic,  Germany,  Poland,  Slovakia,  United Kingdom, 

See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A